ADVM ADVERUM BIOTECHNOLOGIES INC
Executive Summary
Seven of eight tracked institutional funds reduced or exited ADVM positions in Q3 2025, while only Two Sigma doubled a tiny quantitative stake. Aggregate net selling was modest at ~$238K in absolute terms, but the breadth — across mega-passive banks and top quant funds — signals a coordinated reduction in conviction following the biotech's clinical/regulatory events. The selling is concentrated in small pre-commercial positions, suggesting institutional holders are de-risking rather than anticipating a near-term binary catalyst.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$238.0K
▲ Buyers (1)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Two Sigma | DOUBLED | +372.7% | $402.0K | $361.0K |
▼ Sellers (7)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -66.8% | $114.0K | -$34.3K |
| Wells Fargo | NEAR_EXIT | -86% | $461.00 | -$325.00 |
| BofA | NEAR_EXIT | -91.2% | $89.0K | -$72.3K |
| D.E. Shaw | TRIM | -35.9% | $58.0K | $20.0K |
| Citadel | NEAR_EXIT | -77.9% | $168.0K | -$90.1K |
| UBS | TRIM | -60.6% | $30.0K | -$5.2K |
| RenTech | TRIM | -36.3% | $1.2M | $420.0K |
Actionable Insight
The breadth of selling (7 of 8 tracked funds reducing) outweighs the small absolute dollar amounts, signaling a loss of institutional conviction. Monitor upcoming Q4 2025 13F filings in February 2026 for further unwinding. If RenTech also exits by Q4, the institutional thesis will be fully broken.
Key Facts
- 7 sellers vs 1 buyer among tracked 13F filers in Q3 2025
- Aggregate institutional net selling of ~$238K across all positions
- Two Sigma doubled its ADVM stake to only $402K — a de minimis quant position
- Morgan Stanley trimmed 66.8%, Citadel near-exited, BofA near-exited
- Renaissance Technologies, despite a 36.3% share trim, still held $1.6M — the largest remaining tracked position
- No activist filers or dedicated long-only healthcare funds appear in the cluster
Financial Impact
Total tracked institutional selling value of ~$238K across 7 sellers; buying totaled $361K from one fund. Given ADVM's sub-$5M average daily volume and ~$80M market cap, these moves are small in absolute dollar terms but broad in participant count.
Risk Factors
- 13F data is 45+ days stale; positions may already be different, reducing signal relevance
- Total dollar values are small ($238K net) — these moves may not indicate a fundamental view change
- A positive clinical readout or corporate partnership could reverse the selling thesis
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ADVM-2025-Q3 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access